Firm Director Dan Berger Presents at Practising Law Institute’s 2016 Seminar in New York

Practising Law Institute Expert Witness 2016 Seminar
PLI New York Center1177 Avenue of the Americas
New York, NY
June 27, 2016» Read More« Read Less

The PLI Expert Witness 2016 seminar focuses on the crucial benefits and effective use of expert witnesses in complex litigation. Panel presentations by experienced litigators and expert witnesses demystify the challenges of selecting, preparing, and using experts.

Friday, April 22nd
12:30 pm: “Zofran Update” – G&E’s Beth Graham and co-panelists present on the current status of the Zofran litigation.

The national Zofran Lawsuit concerns the use of the prescription drug Zofran and the growing body of evidence linking this drug to an increased risk of birth defects. The lawsuit alleges that the manufacturer of Zofran knew of this severe side effect, but failed to properly inform the United States government and healthcare providers that Zofran could cause significant potential issues, and that the drug required additional testing and research before it should have been widely marketed and prescribed to patients who had better alternative treatments.

Delaware Law Developments 2015: What All Business Lawyers Need to KnowPLI New York Center
1177 Avenue of the Americas
New York, New York 10036
June 4, 2015» Read More« Read Less

Delaware law continues to play a critical role in U.S. corporate and securities law, particularly in today’s challenging and changing business environment. This unique annual program focuses on the important Delaware corporate law developments over the past year and the practical impact on your corporate or legal practice. The very top Delaware corporate law experts from the Delaware judiciary, leading law firms and corporations, and academia, will examine the latest case law and practical trends and share their real-world experiences, insights and advice on the issues of greatest concern to the corporate/securities legal community.

This year’s conference covers updates to some of the most publicized drug and device litigation, the science behind drugs such as Xarelto and certain power morcellators, and a review of the liability and jurisdictional issues relating to the drugs and case filings.

Firm Director Adam Levitt is Panelist at the Center for Animal Law Fall 2013 Symposium, Chicago

The legal, moral and ethical issues surrounding animals in contemporary food production and distribution are the focus of the Center for Animal Law’s annual fall symposium.

“Food Labeling: What Labels Actually Mean for Consumers and Animals”
1:15-2:45Adam Levitt, along with 3 other distinguished panelists, analyze the words on food packages. Cage free, free range, natural, and organic are only some of the hazily-defined terms seen at many grocery stores, and this panel will provide insight into what these words actually mean for consumers and for animals. It will also look at who regulates their usage and sanctions against false advertising. Genetically modified organisms, their benefits, and their effect on human health will also be covered during this segment.

Firm Director Adam Levitt Joins Other Prominent Panelists in a Mass Tort Discussion at the ABA Annual Section of Litigation Conference in Chicago

Firm Director Adam J. Levitt joins Magistrate Judge Sidney Schenkier, of the United States District Court for the Northern District of Illinois, and Professor Francis McGovern, of Duke University School of Law, in a panel discussion on the topic “Disaster Averted, Mass Tort Resolved — Settling Tort Disaster Cases.”

The ABA Section Annual Conference for litigators brings together lawyers and judges from across the country for the latest in trial advocacy… Click here for conference brochure